EUVIMEDEUVIMED entdecken
Open Access

Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide

Xiao Xiao, Yanan Fu, Wanling You, Congcong Huang, Feng Zeng, Xinsheng Gu, Xiaoguang Sun, Jian Li iD, Qiwei Zhang iD, Weixing Du, Gong Cheng iD, Zhixin Liu iD und 1 weitere

Journal of Virology · 14.05.2024 · 98 (5)

DOI: 10.1128/jvi.01573-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 14.05.2024. Verfasst von Xiao Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Renmin Hospital, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, COVID-19, SARS-CoV-2, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and characterized by dysregulated immune response. Studies have shown that the SARS-CoV-2 accessory protein ORF7b induces host cell apoptosis through the tumor necrosis factor alpha (TNF-α) pathway and blocks the production of interferon beta (IFN-β). The underlying mechanism remains to be investigated. In this study, we found that ORF7b facilitated viral infection and production, and inhibited the RIG-I-like receptor (RLR) signaling pathway through selectively interacting with mitochondrial antiviral-signaling protein (MAVS). MAVS 439-466 region and MAVS Lys461 were essential for the physical association between MAVS and ORF7b, and the inhibition of the RLR signaling pathway by ORF7b. MAVS K461 /K63 ubiquitination was essential for the RLR signaling regulated by the MAVS–ORF7b complex. ORF7b interfered with the recruitment of tumor necrosis factor receptor-related factor 6 (TRAF6) and the activation of the RLR signaling pathway by MAVS. Furthermore, interfering peptides targeting the ORF7b complex reversed the ORF7b-suppressed MAVS-RLR signaling pathway. The most potent interfering peptide V disrupts the formation of ORF7b tetramers, reverses the levels of the ORF7b-inhibited physical association between MAVS and TRAF6, leading to the suppression of viral growth and infection. Overall, this study provides a mechanism for the suppression of innate immunity by SARS-CoV-2 infection and the mechanism-based approach via interfering peptides to potentially prevent SARS-CoV-2 infection. IMPORTANCE The pandemic coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and continues to be a threat to public health. It is imperative to understand the biology of SARS-CoV-2 infection and find approaches to prevent SARS-CoV-2 infection and ameliorate COVID-19. Multiple SARS-CoV-2 proteins are known to function on the innate immune response, but the underlying mechanism remains unknown. This study shows that ORF7b inhibits the RIG-I-like receptor (RLR) signaling pathway through the physical association between ORF7b and mitochondrial antiviral-signaling protein (MAVS), impairing the K63-linked MAVS polyubiquitination and its recruitment of tumor necrosis factor receptor-related factor 6 (TRAF6) to MAVS. The most potent interfering peptide V targeting the ORF7b–MAVS complex may reverse the suppression of the MAVS-mediated RLR signaling pathway by ORF7b and prevent viral infection and production. This study may provide new insights into the pathogenic mechanism of SARS-CoV-2 and a strategy to develop new drugs to prevent SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingCOVID-19SARS-CoV-2Signal TransductionAnimalsHumansApoptosisDEAD Box Protein 58HEK293 CellsImmunity, InnateInterferon-betaReceptors, ImmunologicTNF Receptor-Associated Factor 6Tumor Necrosis Factor-alphaUbiquitinationViral Regulatory and Accessory ProteinsViral Proteins

Stichwörter der Autor:innen

MAVSORF7bRLR signaling pathwaySARS-CoV-2interfering peptide

Substanzen

Adaptor Proteins, Signal TransducingDEAD Box Protein 58Interferon-betaReceptors, ImmunologicTNF Receptor-Associated Factor 6Tumor Necrosis Factor-alphaViral Regulatory and Accessory ProteinsORF7b protein, SARS-CoV-2Viral Proteins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Renmin Hospital, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China.
  • Institute of Virology, Shiyan Key Laboratory of Virology, Hubei University of Medicine, Shiyan, China.
  • Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
  • Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
  • New Cornerstone Science Laboratory, Tsinghua-Peking Joint Center for Life Sciences, School of Basic Medical Sciences, Tsinghua University, Beijing, China.

ORCID-Profile: Jian Li, Qiwei Zhang, Gong Cheng, Zhixin Liu, Long Liu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Xiao, X., Fu, Y., You, W., Huang, C., Zeng, F., Gu, X., Sun, X., Li, J., Zhang, Q., Du, W., Cheng, G., Liu, Z., & Liu, L. (2024). Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide. Journal of Virology, 98(5). https://doi.org/10.1128/jvi.01573-23

Vancouver

Xiao X, Fu Y, You W, Huang C, Zeng F, Gu X, et al. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide. Journal of Virology. 2024;98(5). doi:10.1128/jvi.01573-23

BibTeX
@article{Xiao2024,
  author = {Xiao, Xiao and Fu, Yanan and You, Wanling and Huang, Congcong and Zeng, Feng and Gu, Xinsheng and Sun, Xiaoguang and Li, Jian and Zhang, Qiwei and Du, Weixing and Cheng, Gong and Liu, Zhixin and Liu, Long},
  title = {Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {5},
  doi = {10.1128/jvi.01573-23}
}
Kostenlos starten →